Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Researchers have investigated the use of zebrafish to identify self-renewing tumor stem cells in prostate cancer, and they say the model could be more beneficial for predicting therapy response, compared with traditional experimental models.
Researchers from Rutgers Cancer Institute of New Jersey say that prostate cancers contain self-renewing tumor stem cells called tumor-initiating cells (TICs). These cells can grow and spread at an uncontrollable rate.
Previous studies have shown that TICs are resistant to standard chemotherapy, the researchers say. Therefore, they emphasize the need to create a treatment strategy that targets the way the cells are able to renew.
But to get there, the researchers say there need to be better ways of identifying TICs.
For their study, published in The Prostate, the researchers analyzed prostate cancer samples from patients who were diagnosed with the disease at Rutgers Cancer Institute of New Jersey between 2008 and 2012.
The researchers first identified tumor cells from the prostate cancer samples by using fluorescent markers.
Traditional methods for identifying TICs include dye staining or cell sorting. But the scientists created a new method that involved "enriching" the tumor cells for TICs, by allowing them to bind with collagen - a glue-like protein that is able to hold together skin, connective and prostate tissues.
The TICs were then transplanted into mice and zebrafish embryos in order to determine their growth and spread frequency.
The researchers discovered that a small amount of the cells that demonstrated binding properties could potentially lead to tumor development and spread, and that this detection was better understood using the zebrafish model.
The researchers say this is due to the zebrafish's "translucent nature," which means observation can be made without the need for invasive procedures. Furthermore, the zebrafish demonstrate a lack of immune response to tumor cells.
Dr. Hatem E. Sabaawy, a scientist at Rutgers Cancer Institute and study author, explains that these findings are an important step toward targeting TICs in prostate cancer:
"The self-renewing properties found in prostate TICs are regulated through molecular pathways within the cell. By targeting these pathways and using a few cells from each patient, there may be an opportunity to control progression and recurrence in multiple cancers.
The zebrafish model enables researchers to examine this pathway to progression in real time, thus having the potential to serve as a better tool for personalized cancer therapy."
Earlier this year, Medical News Today reported on a study suggesting that consuming four or more cups of coffee a day could reduce the risk of prostate cancer recurrence and disease progression.
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion, DOI: 10.1002/pros.22740, Nitu Bansal, Stephani Davis, Irina Tereshchenko, Tulin Budak-Alpdogan, Hua Zhong, Mark N. Stein, Isaac Yi Kim, Robert S. DiPaola, Joseph R. Bertino, Hatem E. Sabaawy, published in The Prostate, 24 October 2013. Abstract
Translucent Zebrafish Model Shown to be Useful Tool in Identifying Self-Renewing Properties of Prostate Cancer Stem Cells, news release from Rutgers Cancer Institute of New Jersey, accessed 29 October 2014.
Visit our Prostate / Prostate Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Whiteman, Honor. "Zebrafish may predict therapy response to prostate cancer." Medical News Today. MediLexicon, Intl., 30 Oct. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/articles/268089>
Whiteman, H. (2013, October 30). "Zebrafish may predict therapy response to prostate cancer." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/268089.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.